Brief: Pharnext Announces Issuance Of New Composition Of Matter Patents For PLEODRUG PXT3003 And PXT864

Pharnext SCA

18/07/2018 06:34

July 18 (Reuters) - PHARNEXT SA  PHARN.PA :
    * PHARNEXT ANNOUNCES ISSUANCE OF NEW COMPOSITION OF MATTER
PATENTS
COVERING FIRST-IN-CLASS PLEODRUG(TM) PXT3003 AND PXT864
    * EXPANDS FOUNDATIONAL PATENT PROTECTION FOR PHARNEXT'S
INNOVATIVE
DRUG COMBINATIONS AS NEW PRODUCTS
    * TWO PLEODRUG PRODUCTS WERE DEVELOPED USING PHARNEXT'S
RESEARCH
AND DEVELOPMENT PLATFORM
    * CANADIAN INTELLECTUAL PROPERTY OFFICE ISSUED COMPOSITION
OF
MATTER PATENT FOR PXT3003, WHICH EXPIRES IN 2030
    * EUROPEAN PATENT OFFICE ISSUED A COMPOSITION OF MATTER
PATENT FOR
PXT864, WHICH EXPIRES IN 2032

Source text for Eikon:  ID:nEQ83qkKza 
Further company coverage:  PHARN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))